Research To Practice | Oncology Videos

Latest Episodes:

Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO Apr 30, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer | Faculty Presentation 2: Future Directions in the Use of Oral SERDs for HR-Positive, HER2-Negative BC — Erica Mayer, MD, MPH, FASCO

CME information and select publications

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances Apr 30, 2026

Show notes

Featuring perspectives from Dr Aditya Bardia and Dr Erica Mayer, including the following topics:

Introduction: How Selective Estrogen Receptor Degraders (SERDs) Work (0:00)
Second-Line Treatment for Metastatic Breast Cancer (16:01)
First-Line Therapy for Metastatic Disease (33:19)
Adjuvant Therapy (35:26)
Toxicity, Quality of Life (47:59)
New Directions (55:22)

CME information and select publications

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances Apr 27, 2026

Show notes

Featuring perspectives from Dr Suresh S Ramalingam and Dr Helena Yu, including the following topics:

Introduction: Genomics of EGFR (and HER2) (0:00)
Metastatic Disease (9:30)
Localized Disease (30:22)
EGFR Exon 20 Insertion Mutations (46:57)
New Agents (54:20)

CME information and select publications

EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD Apr 27, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer | Faculty Presentation 2: Other Relevant Topics in EGFR-Mutant NSCLC (eg, Nonmetastatic Disease, Exon 20 Insertion Mutations, Novel Agents) — Suresh S Ramalingam, MD

CME information and select publications

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD Apr 27, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer | Faculty Presentation 1: Management of Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) — Helena Yu, MD

CME information and select publications

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium Apr 25, 2026

Show notes

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

Role of PD-L1 status, tumor histology and pulmonary disease in selection of immune checkpoint inhibition as up-front therapy (0:00)
Impact of metastatic site and autoimmune disease on clinical decision-making in the use of immune checkpoint inhibition (5:56)
Biomarker assessment approach and treatment selection (10:50)

CME information and select publications

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances Apr 23, 2026

Show notes

Featuring perspectives from Dr Andrew J Armstrong and Dr Scott T Tagawa, including the following topics:

Introduction: Evolution of the Prostate Cancer Model; Prostate Cancer Working Group 4 (PCWG4) (0:00)
Hormonal Therapy (5:48)
Chemotherapy (Docetaxel) (26:38)
PARP Inhibition (29:49)
Radioligand Therapy (36:56)
New Agents (43:37)

CME information and select publications

Prostate Cancer | Scott T Tagawa, MD, MS Apr 23, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 2: Other Available and Emerging Therapeutic Approaches — Scott T Tagawa, MD, MS

CME information and select publications

Prostate Cancer | Andrew J Armstrong, MD, ScM Apr 23, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Andrew J Armstrong, MD, ScM

CME information and select publications

Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances Apr 20, 2026

Show notes

Featuring perspectives from Dr Amir Fathi and Dr Eunice S Wang, including the following topics: